U&I Corporation (056090) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.034x

Based on the latest financial reports, U&I Corporation (056090) has a cash flow conversion efficiency ratio of -0.034x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.27 Billion ≈ $-2.21 Million USD) by net assets (₩94.87 Billion ≈ $64.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is U&I Corporation's balance sheet to measure how much of total assets are equity-financed.

U&I Corporation - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how U&I Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 056090 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

U&I Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of U&I Corporation ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
IG Group Holdings PLC
LSE:IGG
0.144x
CombinedX AB
ST:CX
0.135x
Sports Entertainment Group Ltd
AU:SEG
0.156x
Prozone Realty Limited
NSE:PROZONER
0.044x
Metrofile
JSE:MFL
0.237x
Ribbon Acquisition Corp Unit
NASDAQ:RIBBU
-0.001x
Algoltek Inc
TWO:6684
0.004x
Airtasker Ltd
AU:ART
-0.050x

Annual Cash Flow Conversion Efficiency for U&I Corporation (2015–2025)

The table below shows the annual cash flow conversion efficiency of U&I Corporation from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market value of U&I Corporation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩94.15 Billion
≈ $63.80 Million
₩2.61 Billion
≈ $1.77 Million
0.028x +59.39%
2024-12-31 ₩86.77 Billion
≈ $58.80 Million
₩1.51 Billion
≈ $1.02 Million
0.017x +142.08%
2023-12-31 ₩59.90 Billion
≈ $40.59 Million
₩-2.48 Billion
≈ $-1.68 Million
-0.041x +55.52%
2022-12-31 ₩57.68 Billion
≈ $39.09 Million
₩-5.36 Billion
≈ $-3.64 Million
-0.093x -306.66%
2021-12-31 ₩28.54 Billion
≈ $19.34 Million
₩1.28 Billion
≈ $870.63K
0.045x -43.30%
2020-12-31 ₩27.09 Billion
≈ $18.36 Million
₩2.15 Billion
≈ $1.46 Million
0.079x +242.79%
2019-12-31 ₩37.99 Billion
≈ $25.74 Million
₩-2.11 Billion
≈ $-1.43 Million
-0.056x +26.25%
2018-12-31 ₩39.20 Billion
≈ $26.57 Million
₩-2.95 Billion
≈ $-2.00 Million
-0.075x -165.54%
2017-12-31 ₩54.29 Billion
≈ $36.79 Million
₩-1.54 Billion
≈ $-1.04 Million
-0.028x +52.66%
2016-12-31 ₩59.07 Billion
≈ $40.03 Million
₩-3.54 Billion
≈ $-2.40 Million
-0.060x +14.63%
2015-12-31 ₩62.85 Billion
≈ $42.59 Million
₩-4.41 Billion
≈ $-2.99 Million
-0.070x --

About U&I Corporation

KQ:056090 Korea Medical Devices
Market Cap
$72.50 Million
₩106.98 Billion KRW
Market Cap Rank
#20474 Global
#1080 in Korea
Share Price
₩1036.00
Change (1 day)
-3.09%
52-Week Range
₩1025.00 - ₩1069.00
All Time High
₩1069.00
About

CG MedTech Co.,Ltd. researches, develops, manufactures, and sale of orthopedic medical devices in the healthcare service market. The company offers headless screws, cortex screws, and K-wires and pin; Aspiron and Maxima anterior cervical plate systems for use in anterior interbody screw/plate fixation of the cervical spine; ANAX OCT spinal system, a device for spinal surgery; Velofix PEEK SA cerv… Read more